REFERENCES
- Jain R.K. Delivery of Molecular and Cellular Medicine to Solid Tumors. Adv. Drug Delivery Rev. 1997; 26: 71–90
- Fung L.K., Saltzman W.M. Polymeric Implants for Cancer Chemotherapy. Adv. Drug Delivery Rev. 1997; 26: 209–230
- Dhanikula A.B., Panchagnula R. Localized Paclitaxel Delivery. Int. J. Pharm. 1999; 183: 85–100
- Panchagnula R. Pharmaceutical Aspects of Paclitaxel. Int. J. Pharm. 1998; 172: 1–15
- Spencer C.M., Faulds D. Paclitaxel: A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in the Treatment of Cancer. Drugs 1994; 48: 794–847
- Okataba A.M., Arsenault A.L., Hunter W.L. Taxol: A Potent Inhibitor of Normal and Tumor-Induced Angiogenesis. Proc. Am. Assoc. Cancer Res. 1995; 36: 454
- Millenbaugh N.J., Gan Y., Au J.L.-S. Cytostatic and Apoptotic Effects of Paclitaxel in Human Ovarian Tumors. Pharm. Res. 1998; 15: 122–127
- Mote P.A., Davey M.W., Davey R.A., Oliver L. Paclitaxel Sensitizes Multidrug Resistant Cells to Radiation. Anticancer Drugs 1996; 7: 182–188
- Nicholson K.M., Bibby M.C., Phillips R.M. Influence of Drug Exposure Parameters on the Activity of Paclitaxel in Multicellular Spheroids. Eur. J. Cancer 1997; 33: 1291–1298
- Harper E., Dang W., Lapidus R.G., Garver R.I., Jr. Enhanced Efficacy of a Novel Controlled Release Paclitaxel Formulation (PACLIMER Delivery System) for Local-Regional Therapy of Lung Cancer Tumor Nodules In Mice. Clin. Cancer Res. 1999; 5: 4242–4248
- Winternitz C.I., Jackson J.K., Okataba A.M., Burt H.M. Development of Polymeric Surgical Paste Formulation for Taxol. Pharm. Res. 1996; 13: 368–375
- Park E.-S., Maniar M., Shah J.C. Biodegradable Polyanhydride Devices of Cefazolin Sodium, Bupivacaine, and Taxol for Local Drug Delivery: Preparation and Kinetics and Mechanism of In Vitro Release. J. Control. Release 1998; 52: 179–189
- Lundsted L.G., Schmolka I.R. R.J. CeresaThe Synthesis and Properties of Block Copolymer Surfactants. Block and Graft Copolymerization, . John Wiley and Sons, New York, NY 1976; 1–111
- Paavola A., Yliruusi J., Kojimoto Y., Kalso E., Wahlstrom T., Rosenberg P. Controlled Release of Lidocaine from Injectable Gels and Efficacy in Rat Sciatic Nerve Block. Pharm. Res. 1995; 12: 1997–2002
- Katakam M., Ravis W.R., Banga A.K. Controlled Release of Human Growth Hormone in Rats Following Parenteral Administration of Poloxamer Gels. J. Control. Release 1997; 49: 21–26
- Pandit N.K., McIntyre H.J. Cosolvent Effects on the Gel Formation and Gel Melting Transitions of Pluronic® F127 Gels. Pharm. Dev. Technol. 1997; 2: 181–184
- Lai P.K., Nguyen T., Amiji M. Novel Thermogelling Paclitaxel Formulation for Localized Delivery. Trans. Soc. Biomater. 1999; 22: 321
- Rao M., Kamath R., Rao M.N.A. Protective Effect of Selenomethionine Against Cisplatin-Induced Nephrotoxicity in C57BL/6J Mice Bearing B16F1 Melanoma Without Reducing Antitumor Activity. Pharm. Pharmacol. Commun. 1998; 4: 549–552
- Sharma D., Chelvi T.P., Kaur J., Chakravorty K., De T.K., Maitra A., Ralhan R. Novel Taxol® Formulations: Polyvinylpyrrolidone Nanoparticle-Encapsulated Taxol® for Drug Delivery in Cancer Therapy. Oncol. Res. 1996; 8: 281–286
- Vadnere M., Amidon G., Lindenbaum S., Haslam J.L. Thermodynamic Studies on the Gel–Sol Transition of Some Pluronic Polyols. Int. J. Pharm. 1984; 22: 207–218